After several months of crisis, we can discern some of the key lessons learned from COVID-19 for the future of pharmaceutical policy in Europe.
News & Trends
Procurar
Recentes
- A Formiventos está novamente no ranking das Top 5% melhores PME de Portugal
- Electronic Submission Template for Premarket Approval Applications (PMAs)
- MDSAP Technical Review and Recognition Decision Procedure
- Essential Principles and Content of Predetermined Change Control Plans. Final Document
- Report on the International Active Pharmaceutical Ingredient Inspection Programme 2017 – 2024
- GMP and GDP Question and Answer Guide Version 03 published by ECA
- Guideline on good pharmacovigilance practices (GVP) Module III – Pharmacovigilance inspections (Rev 2)
- Publication of COMBINE Project 2 Sponsors’ guide on safety reporting in combined studies